Table 2 Clinicopathological characteristics of the patients with gastric cancer and healthy control
From: Effect of IL-10-producing B cells in peripheral blood and tumor tissue on gastric cancer
Patients with gastric cancer N = 42 | Healthy Control N = 13 | P value | ||
|---|---|---|---|---|
Age, mean (SD) | 64.61 (± 10.41) | 45.77 (± 19.12) | < 0.001 | |
Sex (M:F ratio) | M | 30 (71.4) | 5 (38.5) | 0.031 |
F | 12 (28.6) | 8 (61.5) | ||
BMI, mean (SD) | 23.77 (± 3.58) | 25.39 (± 6.00) | 0.346 | |
ECOG | 0 | 34 (80.9) | 11 (84.6) | 0.765 |
1 | 8 (19.0) | 2 (15.4) | ||
2 | 0 | |||
Smoking (%) | Never | 16 (38.0) | 12 (92.3) | 0.003 |
Quit | 11 (26.1) | 0 | ||
Active | 15 (35.7) | 1 (7.7) | ||
Alcohol (%) | Never | 28 (66.6) | 8 (61.5) | 0.357 |
Social | 10 (23.8) | 5 (38.5) | ||
Heavy | 4 (9.5) | 0 | ||
Comorbidities | Hypertension | 19 (45.2) | 1 (7.7) | 0.018 |
DM | 7 (16.6) | 2 (15.4) | ||
Cardiovascular | 3 (7.1) | 0 | ||
Pulmonary | 2 (4.7) | 0 | ||
pT stage | T1 | 20 (47.6) | ||
T2-4 | 22 (52.3) | |||
pN stage | N0 | 23 (54.7) | ||
N1-3 | 19 (45.2) | |||
pM stage | M0 | 41 (97.6) | ||
M1 | 1 (2.3) | |||
pStage 8th | I | 23 (54.7) | ||
II | 8 (19.0) | |||
III | 10 (23.8) | |||
IV | 1 (2.3) | |||
Differentiation | Differentiated | 13 (30.9) | ||
Undifferentiated | 29 (69.0) | |||
Lauren | Intestinal | 13 (30.9) | ||
Diffuse/Mixed | 26 (61.9) | |||
Lymphatic invasion | Negative | 24 (57.1) | ||
Positive | 18 (42.8) | |||
Vascular invasion | Negative | 38 (90.1) | ||
Positive | 4 (9.5) | |||
Neural invasion | Negative | 29 (69.0) | ||
Positive | 13 (30.9) |